Related Experiment Videos
Serum prolactin levels following augmentation mammaplasty
Plastic and Reconstructive Surgery
|August 1, 1981
Summary
Augmentation mammaplasty with Silastic implants did not significantly alter serum prolactin levels in women. This study suggests breast implants may not cause chronic elevation of prolactin or galactorrhea.
Area of Science:
- Plastic Surgery
- Endocrinology
Background:
- Augmentation mammaplasty is a common cosmetic procedure.
- Concerns exist regarding potential chronic irritation from breast implants and hormonal changes.
Purpose of the Study:
- To investigate the relationship between augmentation mammaplasty and serum prolactin levels.
- To determine if breast implants act as a chronic stimulus for prolactin elevation or galactorrhea.
Main Methods:
- A prospective study involving eleven healthy female subjects undergoing augmentation mammaplasty.
- Serum prolactin levels were measured pre-surgery and at 1, 3 weeks, and 3 months post-surgery.
Main Results:
- No significant changes in serum prolactin levels were observed post-surgery.
- Four subjects evaluated at 3 months also showed unchanged prolactin levels.
- No instances of galactorrhea were reported during the observation period.
Conclusions:
- Augmentation mammaplasty with Silastic implants does not appear to be a chronic stimulus for elevated prolactin levels.
- The procedure is unlikely to cause galactorrhea in the absence of other factors.